Dicerna Pharmaceuticals Inc Quick Ratio (DRNA) starting from the third quarter 2021 to third quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Dicerna Pharmaceuticals Inc   (NASDAQ: DRNA)

Dicerna Pharmaceuticals Inc 's Quick Ratio

DRNA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2021, Quick Ratio fell to 0.69 a new company low.

Within Major Pharmaceutical Preparations industry 348 other companies have achieved higher Quick Ratio than Dicerna Pharmaceuticals Inc in third quarter 2021. While Quick Ratio total ranking has improved so far during the Q3 2021 to 2332, from total ranking in the second quarter 2021 at 2669.

Explain Quick Ratio?
How much Cash & cash equivalents DRNA´s has?
What are DRNA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DRNA/financial-strength
https://api.csimarket.com/api/v1/companies/DRNA/fundamentals
https://api.csimarket.com/api/v1/companies/DRNA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
DRNA Quick Ratio (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2 		(Mar 31 2021)
Q1 		(Dec 31 2020)
Q4 		(Sep 30 2020)
Q3
Y / Y Current Liabilities Change -0.2 %
Y / Y Cash & cash equivalent Change -72.82 %
Quick Ratio MRQ 0.69
DRNA's Total Ranking # 2332
Seq. Current Liabilities Change 15.24 %
Seq. Cash & cash equivalent Change -25.07 %



Quick Ratio third quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 349
Healthcare Sector # 754
Overall Market # 2332


Quick Ratio Statistics
High Average Low
25.33 7.85 0.69
(Jun 30 2014)   (Sep 30 2021)




Financial Statements
Dicerna Pharmaceuticals Inc 's Current Liabilities $ 239 Millions Visit DRNA's Balance sheet
Dicerna Pharmaceuticals Inc 's Cash & cash equivalent $ 166 Millions Visit DRNA's Balance sheet
Source of DRNA's Sales Visit DRNA's Sales by Geography


Cumulative Dicerna Pharmaceuticals Inc 's Quick Ratio

DRNA's Quick Ratio for the trailling 12 Months

DRNA Quick Ratio

 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months 		(Mar 31 2021)
12 Months 		(Dec 31 2020)
12 Months 		(Sep 30 2020)
12 Months
Y / Y Current Liabilities TTM Growth -18.71 %
Y / Y Cash & cash equivalent TTM Growth -35.7 %
Quick Ratio TTM 1.86
Total Ranking TTM # 4677
Seq. Current Liabilities TTM Growth -0.06 %
Seq. Cash & cash equivalent TTM Growth -22.83 %

Quick ratio ranking by company, industry and sector >> Back to DRNA Financial Strength Comparisons >> Go to Compare DRNA Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in DRNA's Current Liabilities to $239.30 millions, cumulative Quick Ratio to 1.86 below the DRNA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 514 other companies have achieved higher Quick Ratio than Dicerna Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2021 from 4369 to 4677.

Explain Quick Ratio?
How much Cash & cash equivalents DRNA´s has?
What are DRNA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 515
Healthcare Sector # 1017
Within the Market # 4677


trailing twelve months Quick Ratio Statistics
High Average Low
12.97 2.96 0.74
(Dec 31 2014)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2021 MRQ Cash & cash equivalentSep 30 2021 MRQ Current Liabilities
Apexigen Inc   1.87 $ 0.274  Millions$ 0.147  Millions
Ptc Therapeutics inc   1.87 $ 867.943  Millions$ 465.261  Millions
Catalent Inc   1.84 $ 2,019.000  Millions$ 1,096.000  Millions
Innovation Pharmaceuticals Inc   1.81 $ 11.284  Millions$ 6.227  Millions
Athersys Inc  1.79 $ 49.671  Millions$ 27.680  Millions
Zealand Pharma A  1.78 $ 1,150.665  Millions$ 647.906  Millions
Procyon Corporation  1.77 $ 1.296  Millions$ 0.733  Millions
Jazz Pharmaceuticals Plc  1.76 $ 1,343.560  Millions$ 763.279  Millions
Baudax Bio Inc   1.73 $ 24.922  Millions$ 14.442  Millions
Verrica Pharmaceuticals Inc   1.71 $ 79.495  Millions$ 46.374  Millions
REST EZ Inc.  1.68 $ 0.580  Millions$ 0.345  Millions
Thorne Healthtech Inc   1.64 $ 76.691  Millions$ 46.879  Millions
Scopus Biopharma Inc   1.62 $ 3.632  Millions$ 2.237  Millions
Aptevo Therapeutics Inc   1.61 $ 52.118  Millions$ 32.380  Millions
Optinose Inc   1.57 $ 84.226  Millions$ 53.627  Millions
Agile Therapeutics Inc  1.55 $ 14.735  Millions$ 9.531  Millions
Cumberland Pharmaceuticals Inc   1.53 $ 25.843  Millions$ 16.851  Millions
Cti Biopharma Corp   1.53 $ 95.276  Millions$ 62.342  Millions
Rockwell Medical inc   1.53 $ 33.203  Millions$ 21.756  Millions
Clovis Oncology inc   1.53 $ 171.949  Millions$ 112.693  Millions
Aditxt Inc   1.52 $ 5.469  Millions$ 3.601  Millions
Evolus Inc   1.51 $ 107.796  Millions$ 71.303  Millions
Intelgenx Technologies Corp   1.51 $ 12.236  Millions$ 8.096  Millions
Allarity Therapeutics Inc   1.49 $ 5.584  Millions$ 3.740  Millions
Camp4 Therapeutics Corporation  1.48 $ 101.051  Millions$ 68.214  Millions
Cartesian Therapeutics Inc   1.45 $ 138.663  Millions$ 95.616  Millions
Bellicum Pharmaceuticals Inc   1.41 $ 19.266  Millions$ 13.702  Millions
Clever Leaves Holdings Inc   1.40 $ 45.762  Millions$ 32.645  Millions
Kamada Ltd   1.37 $ 99.840  Millions$ 73.067  Millions
One World Products Inc   1.36 $ 1.923  Millions$ 1.413  Millions

Date modified: 2026-10-07T00:41:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.